Octreotide Oral Tablet (Enteris BioPharma)

N/A

Report date: 2024/08/08 17:10:00

Base Information

Drug NameOctreotide Oral Tablet (Enteris BioPharma)
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionSomatostatin receptor agonists
TargetsSomatostatin receptor
Therapy Area/IndicationsNeuroendocrine Tumors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEnteris Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesEnteris Biopharma Inc
Inactive CompaniesN/A
Active IndicationsNeuroendocrine Tumors
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A